Back

Document Details

Form
Filing Date
September 16, 2022
Document Date
September 14, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Revance Therapeutics, Inc.
Issuer
REVANCE THERAPEUTICS, INC.